<DOC>
	<DOC>NCT02669641</DOC>
	<brief_summary>The main objective is the assessment of MRI (Magnetic Resonance Imaging) Spectroscopy in patients diagnosed with hepatic steatosis in treatment with combination Silimarin, Phyllanthus Niruri and Choline.</brief_summary>
	<brief_title>Complex Imaging Assessment of Steatosis</brief_title>
	<detailed_description>In the study will be included patients with alcoholic and non-alcoholic steatohepatitis evaluated in Research Center of Gastroenterology and Hepatology and Gastroenterology Clinic of University of Medicine and Pharmacy of Craiova. All the patients will undergo MRI and MRI Spectroscopy (3 Tesla) using PHILIPS INGENIA 3T System for exact steatosis quantification. The eligible patients will be treated with combination Silimarin, Phyllanthus Niruri and Choline (Stoptoxin Forte) for 6 months (in conformity Product Characteristics). After the treatment a new IRM Spectroscopy examination will be performed. All the acquired data will be analyzed and published.</detailed_description>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Choline</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<criteria>steatosis described on abdominal ultrasound chronic viral hepatitis liver cancer abusive alcohol consumption</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Steatosis, Fatty liver, Steatohepatitis</keyword>
</DOC>